Chart of the Week : Global central bank liquidity

Macro
Christopher Dembik

Summary:  Our 'Macro Chartmania' series collects Macrobond data and focuses on a single chart chosen for its relevance.


Click here to download this week's full edition of Macro Chartmania.

Today, we look at the evolution of liquidity injections by central banks. At Saxo, we believe that in the era of central bank power, it is of prime importance to closely monitor the evolution of central bank liquidity to make the appropriate investing decisions. The below chart tracks the evolution of total liquidity injection by the twenty two biggest global central banks expressed in percentage point of global GDP. In the wake of the outbreak, central banks all around the world have opened up widely the wave of liquidity to avoid a liquidity crunch and help companies and households overcoming the consequences of the health crisis. Such a flow of liquidity is unprecedented in modern history, with the combined liquidity injection by the G3 central banks (Fed, ECB and BoJ) representing the stunning level of 9.6 percentage points of global GDP in Q3 this year according to our calculations – a level that has not even been reached during the GFC. The current central bank liquidity impulse is three times bigger than during the Great Recession. So far, the Federal Reserve has been the most important contributor to global central bank liquidity, with a level of injection climbing to 9.3 percentage points of global GDP since the outbreak, followed up by the ECB. This amount of central bank liquidity that has flowed into financial markets is the main explanation behind the strong performance of the equity market over the past few months. With more positive vaccine news in sight, especially the likely FDA’s approval of the Pfizer vaccine on 10 Dec, and more monetary stimulus to come in the next two to three weeks, investors have all reasons to wear rose-colored glasses right now, and get prepared for an ultimate year-end rally in the stock market. When looking a bit forward, we expect central bank liquidity injection will recede next year, as economic recovery will start to materialize, but central banks will continue to act appropriately and will remain accommodative on the long run, thereby avoiding that the level of debt becomes a problem or that interest rates rise too sharply. Among the measures that may be taken, we anticipate additional forward guidance on QE by the Fed and the ECB and the extension of the corporate financing support program by the BoJ.

Disclaimer

The Saxo Bank Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-hk/legal/disclaimer/saxo-disclaimer)

Saxo Capital Markets HK Limited
19th Floor
Shanghai Commercial Bank Tower
12 Queen’s Road Central
Hong Kong

Contact Saxo

Select region

Hong Kong S.A.R
Hong Kong S.A.R

Saxo Capital Markets HK is a company authorised and regulated by the Securities and Futures Commission of Hong Kong. Saxo Capital Markets HK Limited holds a Type 1 Regulated Activity (Dealing in securities); Type 2 Regulated Activity (Dealing in Futures Contract) and Type 3 Regulated Activity (Leveraged foreign exchange trading) licenses (CE No. AVD061). Registered address: 19th Floor, Shanghai Commercial Bank Tower, 12 Queen’s Road Central, Hong Kong

By clicking on certain links on this site, you are aware and agree to leave the website of Saxo Capital Markets, proceed on to the linked site managed by Saxo Group and where you will be subject to the terms of that linked site.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

Please note that the information on this site and any product and services we offer are not targeted at investors residing in the United States and Japan, and are not intended for distribution to, or use by any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation. Please click here to view our full disclaimer.